Exosomes carrying anti‐miR‐214 were shown to reverse cisplatin resistance in GC by sensitizing cells to the drug in vitro, inhibiting tumor growth, and enhancing treatment efficacy in vivo.[98] Suppressing the c‐MET expression is another way to reduce drug resistance upon DDP treatment. This evidence concerns the gene MET and gastric cancer.